Information Journal Paper
APA:
CopyKATAYAMA, R., HUELSMEYER, M.K., MARR, K.A., KURZMAN, I.D., THAMM, D.H., & VAIL, D.M.. (2004). IMATINIB MESYLATE INHIBITS PLATELET-DERIVED GROWTH FACTOR ACTIVITY AND INCREASES CHEMOSENSITIVITY IN FELINE VACCINE-ASSOCIATED SARCOMA. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 54(1), 25-33. SID. https://sid.ir/paper/576443/en
Vancouver:
CopyKATAYAMA R., HUELSMEYER M.K., MARR K.A., KURZMAN I.D., THAMM D.H., VAIL D.M.. IMATINIB MESYLATE INHIBITS PLATELET-DERIVED GROWTH FACTOR ACTIVITY AND INCREASES CHEMOSENSITIVITY IN FELINE VACCINE-ASSOCIATED SARCOMA. CANCER CHEMOTHERAPY AND PHARMACOLOGY[Internet]. 2004;54(1):25-33. Available from: https://sid.ir/paper/576443/en
IEEE:
CopyR. KATAYAMA, M.K. HUELSMEYER, K.A. MARR, I.D. KURZMAN, D.H. THAMM, and D.M. VAIL, “IMATINIB MESYLATE INHIBITS PLATELET-DERIVED GROWTH FACTOR ACTIVITY AND INCREASES CHEMOSENSITIVITY IN FELINE VACCINE-ASSOCIATED SARCOMA,” CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol. 54, no. 1, pp. 25–33, 2004, [Online]. Available: https://sid.ir/paper/576443/en